COPENHAGEN, February 3rd (Reuters). Diabetes drug maker Novo Nordisk released positive sales and earnings guidance for 2021 on Wednesday after releasing expected fourth...
Sodium glucose cotransporter-2 inhibitors (SGLT2) are a newer, second line of medical treatment for treating blood sugar levels in people with type 2 diabetes.SGLT2...